[1] FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer,2015,136(5):E359-E386.
[2] 夏露花,崇乐,王新华,等.靶向逆转NM23对非小细胞肺癌放疗敏感性的影响及其可能机制[J]. 现代医学,2019,47(10):1210-1214.
[3] 许露,朱晓莉,王欢,等.藤黄酸对顺铂诱导A549/DDP细胞凋亡的增敏作用[J]. 东南大学学报(医学版),2019,38(3):438-444.
[4] CARTER L G,D'ORAZIO J A,PEARSON K J.Resveratrol and cancer:focus on in vivo evidence[J]. Endocr Relat Cancer,2014,21(3):R209.
[5] SPIEGEL S,MILSTIEN S.The outs and the ins of sphingosine-1-phosphate in immunity[J]. Nat Rev Immunol,2011,11(6):403-415.
[6] XIE Z,LIU H,GENG M.Targeting sphingosine-1-phosphate signaling for cancer therapy[J]. Sci China Life Sci,2017,60(6):27-42.
[7] URANBILEG B,NISHIKAWA T,IKEDA H,et al.Evidence suggests sphingosine 1-phosphate might be actively generated, degraded, and transported to extracellular spaces with increased S1P 2 and S1P 3 expression in colon cancer[J]. Clin Colorectal Cancer,2018,17(2):e171-e182.
[8] 陈郭玲,周爽,陶惠红,等.白藜芦醇下调CCR7表达对肺癌细胞转移活性的影响[J]. 同济大学学报医学版,2014,35(4):29-34.
[9] 罗美群,黎展华,周继红,等.白藜芦醇对人肺腺癌细胞A549增殖及迁移的抑制作用[J]. 广西医学,2018,40(14):1579-1581,1590.
[10] BEACH J A,ASPURIA P J,CHEON D J,et al.Abstract B09:Sphingosine kinase 1 (SPHK1) is a novel mediator of tumor-stroma interaction in ovarian cancer[J]. Cancer Res,2015,75(1S):B09.
[11] WANG Y C,TSAI C F,CHUANG H L,et al.Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1/S1P/S1PR3 signaling[J]. Oncotarget, 2016,7(20):29563-29576.
[12] PALANGI A,SHAKHSSALIM N,PARVIN M,et al.Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma[J]. ClinTransl Oncol,2019,21:1240-1249.
[13] TAULER J,SIEGLER J,SUN X,et al.Abstract 352:hnRNP A2/B1 regulates S1PR3 expression in lung cancer[J]. Cancer Res,2012,72(8S):352. |